Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 28;39(18):2489-2490.
doi: 10.1016/j.vaccine.2021.03.086. Epub 2021 Mar 30.

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients

Lorenzo Azzi  1 , Daniele Focosi  2 , Francesco Dentali  3 , Andreina Baj  4 , Fabrizio Maggi  5
Affiliations

Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients

Lorenzo Azzi et al. Vaccine. .
No abstract available

Keywords: BNT162b2; COVID-19; SARS-CoV-2; mRNA-1273.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Anti-S1/S2 IgG levels at the day of vaccination (t0), 14 days after the first dose (t1), and 14 days after the second dose (t2) of BNT162b2 vaccine in convalescent versus naïve vaccinees.
See this image and copyright information in PMC

References

    1. Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl J Med. 2020;383:2603–2615. - PMC - PubMed
    1. Widge A.T., Rouphael N.G., Jackson L.A., et al. Durability of responses after SARS-CoV-2 mRNA-1273 vaccination. New Engl J Med. 2020;384(1):80–82. - PMC - PubMed
    1. Ayoub HH, Chemaitelly H, Makhoul M, et al. Epidemiological impact of prioritizing SARS-CoV-2 vaccination by antibody status: mathematical modeling analyses. 2021; 2021.01.10.21249382.
    1. Bonelli F., Sarasini A., Zierold C., et al. Clinical and analytical performance of an automated serological test that identifies S1/S2-neutralizing IgG in COVID-19 patients semiquantitatively. J Clin Microbiol. 2020;58(9):e01224–e1320. - PMC - PubMed
    1. WHO. SAGE roadmap for prioritizing uses of COVID19 vaccines in the context of limited supply. Version 1.1.; 2020.